Long-circulating DNA-complexed biodegradable multiblock copolymers for gene delivery:: degradation profiles and evidence of dysopsonization

被引:36
作者
Bikram, M
Lee, M
Chang, CW
Janát-Amsbury, MM
Kern, SE
Kim, SW
机构
[1] Univ Utah, Dept Pharmaceut & Pharmaceut Chem, CCCD, Salt Lake City, UT 84112 USA
[2] Inha Univ, Coll Med, Clin Res Ctr, Inchon 400711, South Korea
[3] Univ Utah, Dept Pharmaceut & Anesthesiol, Salt Lake City, UT 84112 USA
关键词
biodegradable; gene delivery; PEG copolymers; Nonviral; DNA dosage;
D O I
10.1016/j.jconrel.2004.11.011
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Biodegradable cationic polymers have become promising alternatives to traditional polycationic gene delivery systems in which the high charge densities of high molecular weight polymers contribute significantly to cellular toxicities. Previous research has shown that biodegradable, multiblock copolymers (MBC), PEG-PLL-g-16% His, are efficient gene carriers with negligible cellular toxicities. The present research was designed to characterize the polymer degradation as well as to determine the biodistribution of the MBC after systemic administration. Polymer degradation was performed in buffer as a function of pH, in serum and within polymer/pDNA complexes. The MBC exhibited exponential decay with a half-life (t(1/2)) of similar to 14 min at pH 9.0, similar to 5 h at pH 7.4 and similar to 2 h in serum. However, there was little or no degradation observed at pH 4.0 and the MBC within the complexes degraded between 4 and 8 h in serum. Biodistribution data performed with fluorescently labeled polymer and pDNA revealed that intact complexes remained in the blood up to 3 days, which was also reflected in the organs as a function of time. Therefore, the cumulative data suggest that PEG may be sterically stabilizing complexes in vivo via dysopsonization in which serum proteins mask the complexes from elements of the reticuloendothelial system (RES). (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:221 / 233
页数:13
相关论文
共 28 条
[1]   Biodegradable poly (ethylenimine) for plasmid DNA delivery [J].
Ahn, CH ;
Chae, SY ;
Bae, YH ;
Kim, SW .
JOURNAL OF CONTROLLED RELEASE, 2002, 80 (1-3) :273-282
[2]   Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol) [J].
Allen, C ;
Dos Santos, N ;
Gallagher, R ;
Chiu, GNC ;
Shu, Y ;
Li, WM ;
Johnstone, SA ;
Janoff, AS ;
Mayer, LD ;
Webb, MS ;
Bally, MB .
BIOSCIENCE REPORTS, 2002, 22 (02) :225-250
[3]   Formation of an intrapolymer complex from human serum albumin and poly(ethylene glycol) [J].
Azegami, S ;
Tsuboi, A ;
Izumi, T ;
Hirata, M ;
Dubin, PL ;
Wang, BL ;
Kokufuta, E .
LANGMUIR, 1999, 15 (04) :940-947
[4]   Biodegradable poly(ethylene glycol)-co-poly(L-lysine)-g-histidine multiblock copolymers for nonviral gene delivery [J].
Bikram, M ;
Ahn, CH ;
Chae, SY ;
Lee, MY ;
Yockman, JW ;
Kim, SW .
MACROMOLECULES, 2004, 37 (05) :1903-1916
[5]  
BOLTON PH, 1978, NUCLEIC ACIDS RES, V5, P4891
[6]   French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID) -: Position statement from the European Society of Gene Therapy (ESGT) [J].
Gänsbacher, B ;
Danos, O ;
Dickson, G ;
Thielemans, K ;
Cosset, FL ;
Deglon, N ;
Dilber, MS ;
Galun, E ;
Klatzmann, D ;
Mavilio, F ;
Taylor, N .
JOURNAL OF GENE MEDICINE, 2003, 5 (01) :82-84
[7]   Polyion complex micelles as vectors in gene therapy - pharmacokinetics and in vivo gene transfer [J].
Harada-Shiba, M ;
Yamauchi, K ;
Harada, A ;
Takamisawa, I ;
Shimokado, K ;
Kataoka, K .
GENE THERAPY, 2002, 9 (06) :407-414
[8]  
HIXON SC, 1975, J MOL BIOL, V92, P319, DOI 10.1016/0022-2836(75)90231-4
[9]   Folate-targeted gene transfer in vivo [J].
Hofland, HEJ ;
Masson, C ;
Iginla, S ;
Osetinsky, I ;
Reddy, JA ;
Leamon, CP ;
Scherman, D ;
Bessodes, M ;
Wils, P .
MOLECULAR THERAPY, 2002, 5 (06) :739-744
[10]   Biodegradable block copolymers as injectable drug-delivery systems [J].
Jeong, B ;
Bae, YH ;
Lee, DS ;
Kim, SW .
NATURE, 1997, 388 (6645) :860-862